stockrowAbsci Corporation (ABSI) vs Mesoblast Limited (MESO)
- Absci Corporation ABSI 10.10 +1.30%
- Mesoblast Limited MESO 13.76 −1.64%
Absci Corporation and Mesoblast Limited are both Biotechnology companies. Absci Corporation and Mesoblast Limited are of similar size ($1.8B and $1.7B). Mesoblast Limited grew revenue faster over the last twelve months: −26.5% against −62.3%. Mesoblast Limited has the higher net margin (−1,091.7% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 18 metrics below, Mesoblast Limited leads on 14 and Absci Corporation on 4.
Valuation
Profitability
| Metric | ABSI | MESO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | (269.72%) | 68.51% |
| Operating margin | (8,084.50%) | (826.28%) | 0.00% |
| Net margin | (7,756.37%) | (1,091.71%) | 0.00% |
| Free cash flow margin | (6,969.83%) | 0.00% | 0.00% |
| Return on equity | (57.72%) | 0.00% | (50.12%) |
| Return on assets | (50.57%) | 0.00% | (45.12%) |
| Return on invested capital | (174.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack